Indian J Pharm Close
 

Figure 4: (A) Sequence alteration of ND4L gene indicated by arrow in the malignant sample compared to the matched blood control, (B) Sequence alteration of ND6 gene of two different controls (a,c) compared to their matched malignant breast tissues (b,d). Sequence alteration between control and case is indicated by arrows

Figure 4: (A) Sequence alteration of ND4L gene indicated by arrow in the malignant sample compared to the matched blood control, (B) Sequence alteration of ND6 gene of two different controls (a,c) compared to their matched malignant breast tissues (b,d). Sequence alteration between control and case is indicated by arrows